Neural's Partner CWE to Open Store No. 16 in the City of Bonn and Invitation to Meet Hanf.com at Mary Jane Berlin 2025
Toronto, Ontario--(Newsfile Corp. - June 6, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on developing therapeutic drugs for mental illnesses related to substance use disorders, and CWE European Holdings Inc. ("CWE"), operating as Hanf.com, one of the Germany's...
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-06-06 7:30 AM EDT | Neural Therapeutics Inc.
Restart Life Introduces BrainBalls(TM) Product Line
Vancouver, British Columbia--(Newsfile Corp. - June 5, 2025) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce the forthcoming launch of BrainBalls™, a functional wellness snack developed in collaboration with Brain Balls Inc. through a strategic joint venture...
Technology, Biotechnology, Health
2025-06-05 8:00 AM EDT | Restart Life Sciences Corp.
Therma Bright Proposes to Amend Certain Warrants and Negotiates Debt Settlements
Toronto, Ontario--(Newsfile Corp. - June 5, 2025) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma Bright" or the "Company") a developer and investment partner specializing in advanced diagnostic and medical device technologies, announces that subject to the approval of the TSX Venture Exchange (the "TSXV"), the Company...
Technology, Biotechnology, Health
2025-06-05 7:12 AM EDT | Therma Bright Inc.
Theralase Annual General Meeting
Toronto, Ontario--(Newsfile Corp. - June 5, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering light, radiation, sound and drug-activated therapeutics for the treatment of cancer, bacteria and viruses, is reminding shareholders of its Annual General and Special Meeting ("AGSM")...
Technology, Biotechnology, Healthcare and Hospitals, Pharmaceuticals
2025-06-05 7:00 AM EDT | Theralase Technologies Inc.
BioHarvest Launches Informed Sport-Certified VINIA DailyChews 2X Formula for Athletes and People with Active Lifestyles
Rehovot, Israel--(Newsfile Corp. - June 4, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced the launch of VINIA® DailyChews 2X Formula, a first-of-its-kind chew designed to increase nitric oxide production and arterial dilation,...
Biotechnology, Pharmaceuticals, Health
2025-06-04 7:00 AM EDT | BioHarvest Sciences Inc.
PlasCred Circular Innovations Inc. berichtet über seine Jahresergebnisse 2024
Calgary, Alberta--(Newsfile Corp. - Dienstag, 3. Juni 2025) - PlasCred Circular Innovations Inc. (CSE: PLAS) (FSE: XV2) ("PlasCred" oder das "Unternehmen"), ein Anbieter sauberer Technologien aus Kanada, der Kunststoffabfälle in erneuerbare industrielle Kohlenwasserstoff-Rohstoffe umwandelt, gibt heute seine geprüften Finanz- und Betriebsergebnisse für das zum 31. Dezember 2024 endende Geschäftsjahr bekannt. Das Unternehmen...
Technology, Biotechnology, Bioplastics
2025-06-03 4:16 PM EDT | PlasCred Circular Innovations Inc.
Bachem Mourns the Loss of Company Founder Dr. H.C. Peter Grogg
Bubendorf, Switzerland--(Newsfile Corp. - June 3, 2025) - The founder and honorary chairman of Bachem (SIX: BANB) Peter Grogg, passed away on Monday, June 2, 2025, at the age of 83. Peter Grogg founded Bachem in 1971 and built the company from a two-person operation...
Biotechnology, Chemical, Healthcare and Hospitals, Pharmaceuticals
2025-06-03 12:49 PM EDT | Bachem Holding AG
Kiora Pharmaceuticals and Senju Pharmaceutical Partner on KIO-301 for the Treatment of Retinal Diseases in Asia
Total potential deal value of $110 million plus royaltiesKiora to receive an immediate $1.25 million exclusive option feeIf the option is exercised, Kiora will receive an additional mid-single digit million up-front payment, development, regulatory, and commercial milestones, plus tiered royalties on sales Encinitas, California--(Newsfile Corp. - June 3, 2025) -...
Biotechnology, Pharmaceuticals
2025-06-03 7:00 AM EDT | Kiora Pharmaceuticals, Inc.
PlasCred Circular Innovations Inc. Reports 2024 Year-End Results
Calgary, Alberta--(Newsfile Corp. - June 3, 2025) - PlasCred Circular Innovations Inc. (CSE: PLAS) (FSE: XV2) ("PlasCred" or the "Company"), a Canadian clean technology company transforming plastic waste into renewable industrial hydrocarbon feedstock, today announces its audited financial and operating results for the year ended December 31, 2024, highlighting key...
Technology, Biotechnology, Bioplastics
2025-06-03 6:00 AM EDT | PlasCred Circular Innovations Inc.
Medicus Pharma Ltd. Announces Closing of $7.0 Million Public Offering
Philadelphia, Pennsylvania--(Newsfile Corp. - June 2, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) (the "Company") today announced the closing of its previously announced public offering of 2,260,000 units, on a "best-efforts" basis, at a price of $3.10 per unit. Each unit consisted of one common share of the Company and...
Banking/Financial Services, Biotechnology, Investment Banking, Health
2025-06-02 1:40 PM EDT | Medicus Pharma Ltd.
PreveCeutical Welcomes Dr. Deepak Sampath, PhD. as Corporate Advisor
Vancouver, British Columbia--(Newsfile Corp. - June 2, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or the "Company"), a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products, is pleased to have appointed Dr. Deepak Sampath as a corporate advisor...
Biotechnology, Pharmaceuticals, Health
2025-06-02 7:00 AM EDT | PreveCeutical Medical Inc.
Defence Therapeutics Opens U.S. Laboratory in Boston-Cambridge Biotech Hub
Montreal, Quebec--(Newsfile Corp. - June 2, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a leading biotechnology company specializing in advanced endosomal escape technologies, is pleased to announce the opening of its first U.S. laboratory in the Boston-Cambridge area. This strategic expansion marks...
Biotechnology, Pharmaceuticals, Health
2025-06-02 3:15 AM EDT | Defence Therapeutics Inc.
Nextleaf Reports Profitable Second Quarter FY25 Results Including Increased Revenue Growth and Positive Net Income Improvement
Vancouver, British Columbia--(Newsfile Corp. - May 30, 2025) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) ("Nextleaf", "OILS", or the "Company"), an innovation-driven life science company and licensed cannabis processor, is pleased to announce its financial results for the second quarter of fiscal year 2025, ended March 31...
Biotechnology, Pharmaceuticals, Cannabis, Cannabis Extractor
2025-05-30 9:00 AM EDT | Nextleaf Solutions Ltd.
Theralase(R) 1Q2025 Financial Statements
Toronto, Ontario--(Newsfile Corp. - May 30, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering light, radiation, sound and drug-activated therapeutics for the treatment of cancer, bacteria and viruses has released the Company's unaudited interim consolidated 1Q2025 financial statements ("Financial...
Technology, Biotechnology, Healthcare and Hospitals, Pharmaceuticals
2025-05-30 7:00 AM EDT | Theralase Technologies Inc.
Medicus Pharma Ltd. Announces Pricing of $7.0 Million Public Offering
Philadelphia, Pennsylvania--(Newsfile Corp. - May 29, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) (the "Company") today announced the pricing of its public offering of 2,260,000 units, on a "best-efforts" basis, at a price of $3.10 per unit. Each unit consists of one common share of the Company and one warrant...
Banking/Financial Services, Biotechnology, Investment Banking, Health
2025-05-29 8:30 PM EDT | Medicus Pharma Ltd.
CORRECTION FROM SOURCE: Theralase to Present Groundbreaking Research at ASTRO 2025
This Press Release removes references to preclinical data that has not yet been presented.Toronto, Ontario--(Newsfile Corp. - May 29, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering light, radiation, sound and drug-activated therapeutics for the treatment of cancer, bacteria and viruses...
Technology, Biotechnology, Healthcare and Hospitals, Pharmaceuticals
2025-05-29 4:30 PM EDT | Theralase Technologies Inc.
Cardiol Therapeutics Reports Results of 2025 Annual General Meeting of Shareholders
Toronto, Ontario--(Newsfile Corp. - May 29, 2025) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on developing anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, announces the results from its Annual General Meeting of Shareholders (the "AGM") held...
Biotechnology, Cannabis, Health, Cannabis Manufacturer
2025-05-29 7:27 AM EDT | Cardiol Therapeutics Inc.
Neural Therapeutics and Hanf.com Sign Strategic Investment and Option Agreement to Create a Science-Backed Botanical Wellness Leader
Toronto, Ontario--(Newsfile Corp. - May 28, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on developing therapeutic drugs for mental illnesses related to substance use disorders, and CWE European Holdings Inc. ("CWE"), operating as Hanf.com, a leading German CBD retailer,...
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-05-28 1:52 PM EDT | Neural Therapeutics Inc.
Theralase to Present Groundbreaking Research at ASTRO 2025
Toronto, Ontario--(Newsfile Corp. - May 28, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering light, radiation, sound and drug-activated therapeutics for the treatment of cancer, bacteria and viruses is proud to announce promising new preclinical results. The Company's latest...
Technology, Biotechnology, Healthcare and Hospitals, Pharmaceuticals
2025-05-28 7:00 AM EDT | Theralase Technologies Inc.
Defence Therapeutics to Attend Bio International Convention in Boston, June 2025
Montreal, Quebec--(Newsfile Corp. - May 28, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing advanced cancer therapeutics and drug delivery technologies, is pleased to announce that its Chief Executive Officer and Chief Operating Officer will be attending the...
Biotechnology, Pharmaceuticals, Health
2025-05-28 3:15 AM EDT | Defence Therapeutics Inc.